Clinical Outcomes in 3343 Children and Adults with Rheumatic Heart Disease from 14 Low-and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)

Liesl Zühlke, Ganesan Karthikeyan, Mark E. Engel, Sumathy Rangarajan, Pam Mackie, Blanche Cupido-Katya Mauff, Shofiqul Islam, Rezeen Daniels, Veronica Francis, Stephen Ogendo, Bernard Gitura, Charles Mondo, Emmy Okello, Peter Lwabi, Mohammed M. Al-Kebsi, Christopher Hugo-Hamman, Sahar S. Sheta, Abraham Haileamlak, Wandimu Daniel, Dejuma Yadeta GoshuSenbeta G. Abdissa, Araya G. Desta, Bekele A. Shasho, Dufera M. Begna, Ahmed Elsayed, Ahmed S. Ibrahim, John Musuku, Fidelia Bode-Thomas, Christopher C. Yilgwan, Ganiyu A. Amusa, Olukemi Ige, Basil Okeahialam, Christopher Sutton, Rajeev Misra, Azza Abul Fadl, Neil Kennedy, Albertino Damasceno, Mahmoud U. Sani, Okechukwu S. Ogah, Taiwo Olunugahuda H.M. Elhassan, Ana Olga Mocumbi, Abiodun M. Adeoye, Phindile Mntla, Dike Ojji, Joseph Mucumbitsi, Koon Teo, Salim Yusuf, Bongani M. Mayosi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

133 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical Outcomes in 3343 Children and Adults with Rheumatic Heart Disease from 14 Low-and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)'. Together they form a unique fingerprint.

Medicine & Life Sciences